240 related articles for article (PubMed ID: 24860787)
1. Genetic Modeling of PIM Proteins in Cancer: Proviral Tagging and Cooperation with Oncogenes, Tumor Suppressor Genes, and Carcinogens.
Aguirre E; Renner O; Narlik-Grassow M; Blanco-Aparicio C
Front Oncol; 2014; 4():109. PubMed ID: 24860787
[TBL] [Abstract][Full Text] [Related]
2. The PIM family of serine/threonine kinases in cancer.
Narlik-Grassow M; Blanco-Aparicio C; Carnero A
Med Res Rev; 2014 Jan; 34(1):136-59. PubMed ID: 23576269
[TBL] [Abstract][Full Text] [Related]
3. The essential role of PIM kinases in sarcoma growth and bone invasion.
Narlik-Grassow M; Blanco-Aparicio C; Cecilia Y; Peregrina S; Garcia-Serelde B; Muñoz-Galvan S; Cañamero M; Carnero A
Carcinogenesis; 2012 Aug; 33(8):1479-86. PubMed ID: 22623646
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of collaborating oncogenes in compound mutant mice.
Berns A; Mikkers H; Krimpenfort P; Allen J; Scheijen B; Jonkers J
Cancer Res; 1999 Apr; 59(7 Suppl):1773s-1777s. PubMed ID: 10197595
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.
Scheijen B; Jonkers J; Acton D; Berns A
J Virol; 1997 Jan; 71(1):9-16. PubMed ID: 8985317
[TBL] [Abstract][Full Text] [Related]
6. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.
Brault L; Gasser C; Bracher F; Huber K; Knapp S; Schwaller J
Haematologica; 2010 Jun; 95(6):1004-15. PubMed ID: 20145274
[TBL] [Abstract][Full Text] [Related]
7. PIM Kinase as an Executional Target in Cancer.
Zhang X; Song M; Kundu JK; Lee MH; Liu ZZ
J Cancer Prev; 2018 Sep; 23(3):109-116. PubMed ID: 30370255
[TBL] [Abstract][Full Text] [Related]
8. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
Schmidt T; Zörnig M; Beneke R; Möröy T
Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
[TBL] [Abstract][Full Text] [Related]
9. The role of PIM1/PIM2 kinases in tumors of the male reproductive system.
Jiménez-García MP; Lucena-Cacace A; Robles-Frías MJ; Narlik-Grassow M; Blanco-Aparicio C; Carnero A
Sci Rep; 2016 Nov; 6():38079. PubMed ID: 27901106
[TBL] [Abstract][Full Text] [Related]
10. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer.
Mikkers H; Allen J; Knipscheer P; Romeijn L; Hart A; Vink E; Berns A
Nat Genet; 2002 Sep; 32(1):153-9. PubMed ID: 12185366
[TBL] [Abstract][Full Text] [Related]
11. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
12. Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2.
van der Lugt NM; Domen J; Verhoeven E; Linders K; van der Gulden H; Allen J; Berns A
EMBO J; 1995 Jun; 14(11):2536-44. PubMed ID: 7781606
[TBL] [Abstract][Full Text] [Related]
13. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
[TBL] [Abstract][Full Text] [Related]
14. Pim kinases in cancer: diagnostic, prognostic and treatment opportunities.
Blanco-Aparicio C; Carnero A
Biochem Pharmacol; 2013 Mar; 85(5):629-643. PubMed ID: 23041228
[TBL] [Abstract][Full Text] [Related]
15. Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.
Koblish H; Li YL; Shin N; Hall L; Wang Q; Wang K; Covington M; Marando C; Bowman K; Boer J; Burke K; Wynn R; Margulis A; Reuther GW; Lambert QT; Dostalik Roman V; Zhang K; Feng H; Xue CB; Diamond S; Hollis G; Yeleswaram S; Yao W; Huber R; Vaddi K; Scherle P
PLoS One; 2018; 13(6):e0199108. PubMed ID: 29927999
[TBL] [Abstract][Full Text] [Related]
16. Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors.
Burger MT; Han W; Lan J; Nishiguchi G; Bellamacina C; Lindval M; Atallah G; Ding Y; Mathur M; McBride C; Beans EL; Muller K; Tamez V; Zhang Y; Huh K; Feucht P; Zavorotinskaya T; Dai Y; Holash J; Castillo J; Langowski J; Wang Y; Chen MY; Garcia PD
ACS Med Chem Lett; 2013 Dec; 4(12):1193-7. PubMed ID: 24900629
[TBL] [Abstract][Full Text] [Related]
17. The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.
Saurabh K; Scherzer MT; Shah PP; Mims AS; Lockwood WW; Kraft AS; Beverly LJ
Oncotarget; 2014 Sep; 5(18):8503-14. PubMed ID: 25238262
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice as a means to study synergism between oncogenes.
Berns A; Breuer M; Verbeek S; van Lohuizen M
Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
[TBL] [Abstract][Full Text] [Related]
19. Proviral integration site for Moloney murine leukemia virus (PIM) kinases promote human T helper 1 cell differentiation.
Tahvanainen J; Kyläniemi MK; Kanduri K; Gupta B; Lähteenmäki H; Kallonen T; Rajavuori A; Rasool O; Koskinen PJ; Rao KV; Lähdesmäki H; Lahesmaa R
J Biol Chem; 2013 Feb; 288(5):3048-58. PubMed ID: 23209281
[TBL] [Abstract][Full Text] [Related]
20. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
